bullish
RJH: Covid Windfall Largely Priced In
We downgrade our recommendation to HOLD rating, from BUY, with new 2022E target price of Bt40.50, +14% from Bt35.50 previously, derived from 27.6xPE, which is +1SD of its 3-year trading average.
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 3-minute read)
Discussions
(Paid Plans Only)
Pi Securities PCL, Thailand
Leading, full-service investment firm in Thailand
Price Chart(Sign Up to Access)
- RJH: 4Q21 Earnings Grew YoY but Drop QoQ10 Mar 2022
- RJH: Building Back Better 22-23E Through Resilient Core Operation14 Dec 2021
- Rajthanee Hospital (RJH TB): Q4 Revenue Growth to Decelerate Sequentially as Covid Tailwind Fades18 Nov 2021
- RJH: Resilient Performance Amidst Covid Situation11 May 2021
- Record High Revenue Thanks to Covid-19 Diagnostics11 Nov 2020
- RJH: Cheap with Growing Potential04 Oct 2019
x